Featured Research

from universities, journals, and other organizations

Retinal Rescue: Cells Derived From Human Embryonic Stem Cells Reverse Retinal Degeneration

Date:
October 2, 2009
Source:
Cell Press
Summary:
A new study reports that transplanted pigment-containing visual cells derived from human embryonic stem cells successfully preserved structure and function of the specialized light-sensitive lining of the eye (known as the retina) in an animal model of retinal degeneration.

A new study reports that transplanted pigment-containing visual cells derived from human embryonic stem cells (hESCs) successfully preserved structure and function of the specialized light-sensitive lining of the eye (known as the retina) in an animal model of retinal degeneration.

Related Articles


The findings, published by Cell Press in the October 2nd issue of the journal Cell Stem Cell, represent an exciting step towards the future use of cell replacement therapies to treat devastating degenerative eye diseases that cause millions of people worldwide to lose their sight.

The retinal pigment epithelium (RPE) is a layer of pigmented cells sandwiched between the visual retinal cells, called photoreceptors, and the nourishing blood vessels at the back of the eye. The RPE provides essential support to the retinal photoreceptors and is critical for normal vision. Deterioration of the RPE plays a central role in the progression of diseases such as age-related macular degeneration and sub-types of retinitis pigmentosa. These conditions are associated with a progressive loss of vision that often leads to blindness.

"Although there are a variety of therapeutic approaches under development to delay the degenerative process, the grim reality is that many patients eventually lose their sight," explains Dr. Benjamin Reubinoff, a senior author of the study. "Cell therapy to replenish the degenerating RPE cells may potentially halt disease progression." Dr. Reubinoff and Dr. Eyal Banin who led the study, with their colleagues from Hadassah-Hebrew University Medical Center in Jerusalem, developed conditions to guide hESCs to differentiate into functional RPE-like cells in the laboratory.

The researchers found that nicotinamide (vitamin B3, NIC) and Activin A, an important growth factor, promoted differentiation of hESCs towards an RPE fate. The hESC-derived RPE-like cells, which could be identified by their characteristic black pigment, exhibited multiple biological properties and genetic markers that define authentic RPE cells. Further, the cells successfully delayed deterioration of retinal structure and function when they were transplanted into an animal model of retinal degeneration caused by RPE dysfunction.

Taken together, the results demonstrate that NIC and Activin A promoted the differentiation of hESCs towards an RPE fate. The hESC-derived cells exhibited the defining characteristics associated with RPE and successfully rescued the retina when transplanted into an animal model of retinal degeneration. "Our findings are an important step towards the potential future use of hESCs to replenish RPE in blinding diseases," concludes Dr. Banin.

The reseacher is Maria Idelson, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Ruslana Alper, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Alexey Obolensky, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Etti Ben-Shushan, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Itzhak Hemo, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Nurit Yachimovich-Cohen, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Hanita Khaner, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Yoav Smith, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Ofer Wiser, CellCure Neurosciences Ltd., Jerusalem, Israel; Michal Gropp, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Malkiel A. Cohen, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Sharona Even-Ram, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Yael Berman-Zaken, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Limor Matzrafi, CellCure Neurosciences Ltd., Jerusalem, Israel; Gideon Rechavi, Pediatric Hemato-Oncology Department and Institute of Hematology, Chaim Sheba Medical Center, Tel-Aviv, Israel; Eyal Banin, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; and Benjamin Reubinoff, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Cite This Page:

Cell Press. "Retinal Rescue: Cells Derived From Human Embryonic Stem Cells Reverse Retinal Degeneration." ScienceDaily. ScienceDaily, 2 October 2009. <www.sciencedaily.com/releases/2009/10/091001163611.htm>.
Cell Press. (2009, October 2). Retinal Rescue: Cells Derived From Human Embryonic Stem Cells Reverse Retinal Degeneration. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2009/10/091001163611.htm
Cell Press. "Retinal Rescue: Cells Derived From Human Embryonic Stem Cells Reverse Retinal Degeneration." ScienceDaily. www.sciencedaily.com/releases/2009/10/091001163611.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins